Saitama, Japan

Naoki Tsuzuike

This inventor holds 1 USPTO granted patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Tsuzuike. Retrieved from https://idiyas.com/inventor/naoki-tsuzuike

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoki Tsuzuike: Innovator in Benzylamine Derivatives

Introduction

Naoki Tsuzuike is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzylamine derivatives. His research focuses on compounds that exhibit excellent pharmacological properties.

Latest Patents

Tsuzuike holds a patent for a benzylamine derivative that provides a compound with satisfactory peroral absorbability and excellent antagonistic activity against NK-1 and NK-2 receptors. This invention is represented by a specific formula and includes the potential for various salts of the compound.

Career Highlights

Tsuzuike is associated with Zeria Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in medicinal chemistry. His work has contributed to the understanding of receptor antagonism and its applications in therapeutic settings.

Collaborations

He has collaborated with notable colleagues, including Hideki Nakamura and Masaaki Nagasawa, to further enhance the research and development efforts within the company.

Conclusion

Naoki Tsuzuike's contributions to the field of pharmaceuticals, particularly through his patent on benzylamine derivatives, highlight his role as an innovator in the industry. His work continues to influence advancements in medicinal chemistry and receptor-targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…